Project, program, and portfolio risk analysis
certified Masterclass
- San Francisco, USA
- November 14-15 | 2023
- 8:00 - 17:00 Local Time
-
Course Leader: Dr. Richard Bayney,
President & Founder of Project & Portfolio Value Creation.
Menu
INTERNATIONAL MASTERCLASS
MASTERCLASS OVERVIEW
Learn how to quantify and manage risk at project, program, and portfolio levels. Assess the extent to which multiple indications and/or lines of therapy affect program risk and valuation. Quantify the likelihood that your R&D pipeline portfolio and commercial portfolio will meet annual corporate targets
AUDIENCE
This masterclass is particularly interesting for industry
professionals across Pharma, Biotech, Medical Devices, and Consumer Care involved in:
- Project, Program & Portfolio Management
- Research
- Clinical Development
- Resource Management
- Forecasting & Competitive Intelligence
- Licensing & Business Development
- Finance
- Commercialization
- Consultants are NOT permitted to attend
MEET THE
Masterclassleader
Dr. Richard Bayney is President of Project & Portfolio Value Creation (PPVC), a consulting boutique that he founded in 2008 which provides training and education in Project, Program, Portfolio, Resource, and Risk Management as well as Business, Strategic, Portfolio, and Scenario Planning services. He is an adjunct faculty member at the University of Pennsylvania.
Dr. Bayney is a 23-year veteran of the Pharmaceutical & Biotechnology industry at Merck & Co., Bayer Corp. and AG, Bristol-Myers Squibb, and Johnson & Johnson Pharmaceutical Research & Development. In his previous position at Johnson & Johnson, Richard was Vice President, Portfolio Management & Decision Analysis. Dr. Bayney obtained his M.Sc. and Ph.D. from the University of London, MBA from Columbia University, and PMP from the Project Management Institute.
TOPIC SNEAK PEEK
- Quantification of project risk using risk decomposition and Decision Trees
- Quantification of program risk using correlated project risks and Decision Trees
- Quantification of portfolio risk using simulation
- Generation of strategic alternatives for Clinical Development, Registration, and Commercialization
- Selecting dominant strategies based on eNPV
- Accounting for commercial uncertainty in the product portfolio using simulation
- Accounting for risk and commercial uncertainty in the pipeline portfolio
- Quantifying the likelihood of meeting corporate growth targets (Long Range Plan)
REGISTRATION
Masterclass
Ticket | November 14-15, 2023
$
2399
-
Access to Project, Program, and Portfolio Risk Analysis Masterclass with Industry Veteran Dr. Richard Bayney.
-
Individual consultancy with the trainer
-
Colored hardcopy of training materials in a binder
-
Electronic copy of trainer's textbook
-
Certificate of completion issued by the trainer
get the latest updates
SubScribe to our newsletter
Our Company
- +421 917 784 274
- HQ: Campus City, Bratislava, Slovakia
- why@whysummits.com
Copyright 2020 Why Summits s.r.o.